Novartis Seeks Eye Care Leadership With Full, $50 Billion Alcon Takeover
Novartis pays $28.1 billion for a further 52 percent stake in Alcon, seeking full control with a further offer to buy out minority shareholders.
Novartis pays $28.1 billion for a further 52 percent stake in Alcon, seeking full control with a further offer to buy out minority shareholders.